<DOC>
	<DOC>NCT02241759</DOC>
	<brief_summary>A study in healthy males and females to see if a high single dose of TA-8995 has an effect on the ECG QTcF interval.</brief_summary>
	<brief_title>Study of the Electrocardiographic Effects of TA-8995</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy male or females of nonchild bearing potential Receiving any other drug therapy Clinically significant medical history Abnormal ECGs or vital signs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>